Free release
(S)-N-(1-(4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)-2-napht

(S)-N-(1-(4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)-2-napht

CAS No. :1130067-06-9MDL No. :MFCD23160355Formula :C26H27ClN4O2Boiling Point :-Linear Structure Formula :-InChI Key :-M.

Sales:Service@apichina.com
CAS No. :1130067-06-9 Brand :Qitai
Formula :C26H27ClN4O2 M.W :462.97

Introduction

CAS No. :1130067-06-9 MDL No. :MFCD23160355
Formula : C26H27ClN4O2 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 462.97 Pubchem ID :-
Synonyms :
CAY10593
Chemical Name :(S)-N-(1-(4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)-2-naphthamide

Physicochemical Properties

Num. heavy atoms : 33
Num. arom. heavy atoms : 19
Fraction Csp3 : 0.31
Num. rotatable bonds : 6
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 137.2
TPSA : 70.13 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -4.72 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.93
Log Po/w (XLOGP3) : 6.21
Log Po/w (WLOGP) : 4.21
Log Po/w (MLOGP) : 3.78
Log Po/w (SILICOS-IT) : 4.47
Consensus Log Po/w : 4.52

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -6.65
Solubility : 0.000103 mg/ml ; 0.000000222 mol/l
Class : Poorly soluble
Log S (Ali) : -7.47
Solubility : 0.0000158 mg/ml ; 0.000000034 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -8.0
Solubility : 0.00000465 mg/ml ; 0.00000001 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 3.67
Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram: